A detailed history of Stifel Financial Corp transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 68,041 shares of SUPN stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,041
Previous 69,315 1.84%
Holding current value
$2.32 Million
Previous $2.36 Million 23.01%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.99 - $33.85 $33,111 - $43,124
-1,274 Reduced 1.84%
68,041 $1.82 Million
Q1 2024

May 13, 2024

BUY
$27.11 - $35.17 $402,908 - $522,696
14,862 Added 27.29%
69,315 $2.36 Million
Q4 2023

Feb 12, 2024

BUY
$22.72 - $29.68 $76,634 - $100,110
3,373 Added 6.6%
54,453 $1.58 Million
Q3 2023

Nov 13, 2023

BUY
$27.57 - $32.91 $272,667 - $325,479
9,890 Added 24.01%
51,080 $1.41 Million
Q2 2023

Aug 14, 2023

BUY
$29.91 - $38.73 $142,491 - $184,509
4,764 Added 13.08%
41,190 $1.24 Million
Q1 2023

May 12, 2023

BUY
$34.93 - $42.03 $3,527 - $4,245
101 Added 0.28%
36,426 $1.32 Million
Q4 2022

Feb 13, 2023

BUY
$31.09 - $37.88 $61,527 - $74,964
1,979 Added 5.76%
36,325 $1.3 Million
Q3 2022

Nov 14, 2022

BUY
$28.79 - $35.41 $90,227 - $110,974
3,134 Added 10.04%
34,346 $1.16 Million
Q2 2022

Aug 15, 2022

BUY
$25.33 - $34.25 $96,988 - $131,143
3,829 Added 13.98%
31,212 $903,000
Q1 2022

May 13, 2022

BUY
$28.51 - $32.9 $42,879 - $49,481
1,504 Added 5.81%
27,383 $885,000
Q4 2021

Feb 14, 2022

BUY
$26.37 - $34.22 $73,677 - $95,610
2,794 Added 12.1%
25,879 $755,000
Q3 2021

Nov 15, 2021

BUY
$23.54 - $31.39 $134,978 - $179,990
5,734 Added 33.05%
23,085 $616,000
Q2 2021

Aug 13, 2021

BUY
$26.72 - $33.19 $73,773 - $91,637
2,761 Added 18.92%
17,351 $534,000
Q1 2021

May 14, 2021

BUY
$24.15 - $31.45 $45,474 - $59,220
1,883 Added 14.82%
14,590 $382,000
Q4 2020

Feb 12, 2021

BUY
$17.7 - $25.81 $22,939 - $33,449
1,296 Added 11.36%
12,707 $320,000
Q3 2020

Nov 16, 2020

BUY
$20.2 - $25.05 $9,069 - $11,247
449 Added 4.1%
11,411 $238,000
Q2 2020

Aug 14, 2020

SELL
$17.09 - $24.89 $29,582 - $43,084
-1,731 Reduced 13.64%
10,962 $260,000
Q1 2020

May 14, 2020

SELL
$14.45 - $24.69 $106,193 - $181,446
-7,349 Reduced 36.67%
12,693 $234,000
Q4 2019

Feb 13, 2020

SELL
$19.93 - $29.13 $385,207 - $563,024
-19,328 Reduced 49.09%
20,042 $468,000
Q3 2019

Nov 19, 2019

BUY
$25.47 - $33.37 $53,741 - $70,410
2,110 Added 5.66%
39,370 $1.08 Million
Q3 2019

Nov 13, 2019

SELL
$25.47 - $33.37 $642,888 - $842,292
-25,241 Reduced 40.38%
37,260 $1.02 Million
Q2 2019

Aug 14, 2019

BUY
$29.96 - $38.87 $837,741 - $1.09 Million
27,962 Added 80.96%
62,501 $2.07 Million
Q1 2019

May 14, 2019

BUY
$32.77 - $41.99 $97,687 - $125,172
2,981 Added 9.45%
34,539 $1.21 Million
Q4 2018

Feb 13, 2019

SELL
$30.84 - $49.51 $35,003 - $56,193
-1,135 Reduced 3.47%
31,558 $1.05 Million
Q3 2018

Nov 13, 2018

SELL
$42.7 - $56.55 $264,184 - $349,874
-6,187 Reduced 15.91%
32,693 $1.65 Million
Q2 2018

Aug 14, 2018

SELL
$44.1 - $59.85 $105,002 - $142,502
-2,381 Reduced 5.77%
38,880 $2.33 Million
Q1 2018

May 11, 2018

SELL
$37.15 - $46.9 $182,703 - $230,654
-4,918 Reduced 10.65%
41,261 $1.9 Million
Q4 2017

Feb 14, 2018

BUY
$36.4 - $42.6 $21,985 - $25,730
604 Added 1.33%
46,179 $1.84 Million
Q3 2017

Nov 13, 2017

BUY
$36.75 - $49.65 $1.67 Million - $2.26 Million
45,575
45,575 $0

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.83B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.